ARCHIVES

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

This article is from The Cancer Letter archive.

Vol. 31 No. 39 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Center Directors Urge NCI To Expand CTEP’s Treatment Referral Cntr.

March 12, 1993

DeVita Accepts “Chop Lie” Cancer Control Elements In CCOP; RFA Delays Until After May NCAB Meeting

March 12, 1982

Eight Win ASCO Young Investigator Awards

August 22, 1986

DeVita Seeks End to Funding For CROS, Reacts With Anger To Charge Of “Central Direction From Washington”

February 20, 1981

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

November 28, 2003

Barbara Rimer and Owen Witte To Be Named Members Of the President’s Cancer Panel

December 9, 2011